Breaking research could help to advance care for overdose patients who’ve taken xylazine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))A novel study published today in ADLM’s journal, Clinical Chemistry, has found that it takes the human body much longer than previously thought to clear xylazine — one of the most popular emerging drugs of abuse in the U.S. This much-needed insight into how the body processes xylazine could improve treatment of overdose patients who’ve taken it.